Efficacy and Safety of Belimumab in Patients With Lupus Nephritis (IMAGE)
Caption
Safety and efficacy profiles were consistent with BLISS-LN overall population, supporting benefits of belimumab treatment in the East Asian population with lupus nephritis.
Credit
Yu et al (AJKD, 2022)
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. Adaptations must be shared under the same terms.
License
CC BY-NC-SA